FDAnews
www.fdanews.com/articles/82008-novartis-injectable-asthma-drug-xolair-given-eu-approval-update

NOVARTIS INJECTABLE ASTHMA DRUG XOLAIR GIVEN EU APPROVAL UPDATE

October 28, 2005

Novartis AG said the European Commission granted marketing authorisation in all 25 EU member states for Xolair, an injectable treatment for severe allergic asthma. The treatment is considered by many experts to be one of the most significant advances in the last 15 years for helping patients with asthma, the Swiss drugmaker said. It was given US FDA approval in June 2003 and has been prescribed to 52,000 patients worldwide -- including people in Australia, Brazil, Canada and Venezuela -- following its approval.

Forbes (http://www.forbes.com/work/feeds/afx/2005/10/27/afx2302335.html)